NR1H4 and metabolic dysfunction-associated steatotic liver disease: In summary, ginsenoside Rh4 can regulate bile acid metabolism-, lipid metabolism-, and liver inflammatory factor-related phenotypes in the liver and intestine through the farnesoid X receptor (FXR) signaling pathway, ultimately exerting a therapeutic effect on NAFLD.